{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:38:47Z","timestamp":1791754727095,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epithelioid angiomyolipoma (EAML) is a rare variant of angiomyolipoma that predominantly consists of epithelioid cells and belongs to the perivascular epithelioid cell neoplasm (PEComa) family. The majority of EAMLs arise in the kidneys, and primary hepatic EAML appears to be much less common than renal EAML. Most PEComas arise sporadically, but may be associated with tuberous sclerosis complex (TSC), an autosomal dominant genetic disorder characterized by germline mutations in the <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> genes. However, PEComas have previously been reported in five patients with Li-Fraumeni syndrome (LFS), which is an inherited cancer susceptibility disorder resulting from germline mutations in the <jats:italic>TP53<\/jats:italic> tumor suppressor gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a 49-year-old female patient with hepatic EAML and pancreatic cancer. Because she had previously been diagnosed with bilateral breast cancer at the age of 30, we performed a comprehensive genetic analysis to identify genetic alterations associated with any cancer predisposition syndrome. Whole-exome sequencing of a blood sample identified a heterozygous germline variant of <jats:italic>TP53<\/jats:italic> (NM_000546.5):c.708C&gt;A, and targeted next-generation sequencing of liver EAML and pancreatic cancer tissue samples demonstrated the same <jats:italic>TP53<\/jats:italic> (NM_000546.5):c.708C&gt;A variant in both. This, plus the patient\u2019s history of early-onset breast cancer, met the 2015 version of the Chompret criteria for diagnosis of LFS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There have been very few case reports regarding the presence of PEComa in LFS, and to the best of our knowledge, this is the first report of EAML of the liver in a patient with LFS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-023-01418-5","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T10:01:54Z","timestamp":1705658514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report\u00a0"],"prefix":"10.1186","volume":"19","author":[{"given":"Yaewon","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gok","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Myoung","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"issue":"4","key":"1418_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969;71(4):747\u201352.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1418_CR2","first-page":"1365","volume":"43","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969;43(6):1365\u201373.","journal-title":"J Natl Cancer Inst"},{"issue":"4985","key":"1418_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250(4985):1233\u20138.","journal-title":"Science"},{"key":"1418_CR4","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.4158\/EP15957.CR","volume":"2","author":"S Jasim","year":"2016","unstructured":"Jasim S, Tamboli P, Lee S-C, Strong LC, Elsayes K, Ayala-Ramirez M, et al. Epithelioid angiomyolipoma in a patient with li-fraumeni syndrome: rare pathologic diagnosis. AACE Clin Case Rep. 2016;2:e251\u20135.","journal-title":"AACE Clin Case Rep"},{"issue":"8","key":"1418_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, et al. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol. 2009;27(8):1250\u20136.","journal-title":"J Clin Oncol"},{"issue":"18","key":"1418_CR6","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48(18):5358\u201362.","journal-title":"Cancer Res"},{"issue":"5","key":"1418_CR7","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54(5):1298\u2013304.","journal-title":"Cancer Res"},{"key":"1418_CR8","first-page":"101","volume":"25","author":"RA Eeles","year":"1995","unstructured":"Eeles RA. Germline mutations in the TP53 gene. Cancer Surv. 1995;25:101\u201324.","journal-title":"Cancer Surv"},{"issue":"1","key":"1418_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jmg.38.1.43","volume":"38","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, et al. Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet. 2001;38(1):43\u20137.","journal-title":"J Med Genet"},{"issue":"21","key":"1418_CR10","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, et al. Revisiting Li-fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345\u201352.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1418_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.anndiagpath.2015.06.003","volume":"19","author":"K Thway","year":"2015","unstructured":"Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol. 2015;19(5):359\u201368.","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"1418_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3350\/cmh.2017.0011","volume":"23","author":"SY Lee","year":"2017","unstructured":"Lee SY, Kim BH. Epithelioid angiomyolipoma of the liver: a case report. Clin Mol Hepatol. 2017;23(1):91\u20134.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1418_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2559.2012.04306.x","volume":"61","author":"A Nonomura","year":"2012","unstructured":"Nonomura A, Enomoto Y, Takeda M, Takano M, Morita K, Kasai T. Angiomyolipoma of the liver: a reappraisal of morphological features and delineation of new characteristic histological features from the clinicopathological findings of 55 tumours in 47 patients. Histopathology. 2012;61(5):863\u201380.","journal-title":"Histopathology"},{"issue":"5","key":"1418_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2559.2000.00848.x","volume":"36","author":"S Yamasaki","year":"2000","unstructured":"Yamasaki S, Tanaka S, Fujii H, Matsumoto T, Okuda C, Watanabe G, et al. Monotypic epithelioid angiomyolipoma of the liver. Histopathology. 2000;36(5):451\u20136.","journal-title":"Histopathology"},{"issue":"2","key":"1418_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00428-007-0509-1","volume":"452","author":"G Martignoni","year":"2008","unstructured":"Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008;452(2):119\u201332.","journal-title":"Virchows Arch"},{"key":"1418_CR16","doi-asserted-by":"publisher","first-page":"906981","DOI":"10.1155\/2015\/906981","volume":"2015","author":"K Neofytou","year":"2015","unstructured":"Neofytou K, Famularo S, Khan AZ. PEComa in a young patient with known li-fraumeni syndrome. Case Rep Med. 2015;2015:906981.","journal-title":"Case Rep Med"},{"issue":"1","key":"1418_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13569-020-00143-7","volume":"10","author":"MDM Galera Lopez","year":"2020","unstructured":"Galera Lopez MDM, Marquez Rodas I, Agra Pujol C, Garcia Perez A, Velasco Sanchez E, Alvarez AR. Simultaneous diagnosis of liver PEComa in a family with known Li-Fraumeni syndrome: a case report. Clin Sarcoma Res. 2020;10(1):24.","journal-title":"Clin Sarcoma Res"},{"key":"1418_CR18","doi-asserted-by":"publisher","first-page":"849004","DOI":"10.3389\/fonc.2022.849004","volume":"12","author":"H Butz","year":"2022","unstructured":"Butz H, Lovey J, Szentkereszty M, Bozsik A, Toth E, Patocs A. Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53. Front Oncol. 2022;12:849004.","journal-title":"Front Oncol"},{"issue":"3","key":"1418_CR19","first-page":"212","volume":"39","author":"S Caliskan","year":"2022","unstructured":"Caliskan S, Akar OS, Gun S, Kefeli M. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies. Turk Patoloji Derg. 2022;39(3):212.","journal-title":"Turk Patoloji Derg"},{"issue":"6","key":"1418_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","volume":"39","author":"NP Agaram","year":"2015","unstructured":"Agaram NP, Sung YS, Zhang L, Chen CL, Chen HW, Singer S, et al. Dichotomy of genetic abnormalities in pecomas with therapeutic implications. Am J Surg Pathol. 2015;39(6):813\u201325.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1418_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00000478-199806000-00003","volume":"22","author":"G Martignoni","year":"1998","unstructured":"Martignoni G, Pea M, Bonetti F, Zamboni G, Carbonara C, Longa L, et al. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol. 1998;22(6):663\u201372.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1418_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/1066896912441829","volume":"20","author":"Z Bing","year":"2012","unstructured":"Bing Z, Yao Y, Pasha T, Tomaszewski JE, Zhang PJ. p53 in pure epithelioid PEComa: an immunohistochemistry study and gene mutation analysis. Int J Surg Pathol. 2012;20(2):115\u201322.","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"1418_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00000478-200204000-00017","volume":"26","author":"K Kawaguchi","year":"2002","unstructured":"Kawaguchi K, Oda Y, Nakanishi K, Saito T, Tamiya S, Nakahara K, et al. Malignant transformation of renal angiomyolipoma: a case report. Am J Surg Pathol. 2002;26(4):523\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1418_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000510241","volume":"98","author":"S Akumalla","year":"2020","unstructured":"Akumalla S, Madison R, Lin DI, Schrock AB, Yakirevich E, Rosenzweig M, et al. Characterization of clinical cases of malignant pecoma via comprehensive genomic profiling of DNA and RNA. Oncology. 2020;98(12):905\u201312.","journal-title":"Oncology"},{"issue":"1","key":"1418_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou A, Achatz MIW, Hainaut P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol. 2018;30(1):23\u20139.","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"1418_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jnci\/djy001","volume":"110","author":"HQ Rana","year":"2018","unstructured":"Rana HQ, Gelman R, LaDuca H, McFarland R, Dalton E, Thompson J, et al. Differences in TP53 mutation carrier phenotypes emerge from panel-based testing. J Natl Cancer Inst. 2018;110(8):863\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1418_CR27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","volume":"28","author":"T Frebourg","year":"2020","unstructured":"Frebourg T, BajalicaLagercrantz S, Oliveira C, Magenheim R, Evans DG, European Reference Network G. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet. 2020;28(10):1379\u201386.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"1418_CR28","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","volume":"7","author":"CP Kratz","year":"2021","unstructured":"Kratz CP, Freycon C, Maxwell KN, Nichols KE, Schiffman JD, Evans DG, et al. Analysis of the Li-Fraumeni spectrum based on an international germline tp53 variant data set: an international agency for research on cancer tp53 database analysis. JAMA Oncol. 2021;7(12):1800\u20135.","journal-title":"JAMA Oncol"},{"issue":"12","key":"1418_CR29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","volume":"22","author":"KC de Andrade","year":"2021","unstructured":"de Andrade KC, Khincha PP, Hatton JN, Frone MN, Wegman-Ostrosky T, Mai PL, et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol. 2021;22(12):1787\u201398.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1418_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/humu.23673","volume":"40","author":"KC de Andrade","year":"2019","unstructured":"de Andrade KC, Frone MN, Wegman-Ostrosky T, Khincha PP, Kim J, Amadou A, et al. Variable population prevalence estimates of germline TP53 variants: a gnomAD-based analysis. Hum Mutat. 2019;40(1):97\u2013105.","journal-title":"Hum Mutat"},{"issue":"4","key":"1418_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3322\/caac.21560","volume":"69","author":"WS El-Deiry","year":"2019","unstructured":"El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, et al. The current state of molecular testing in the treatment of patients with solid tumors, 2019. CA Cancer J Clin. 2019;69(4):305\u201343.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1418_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(1):77\u2013102.","journal-title":"J Natl Compr Canc Netw"},{"issue":"18","key":"1418_CR33","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.3390\/cancers14184499","volume":"14","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, Tang M, Rajaram S, O\u2019Grady S, Crown J. Targeting mutant p53 for cancer treatment: moving closer to clinical use? Cancers (Basel). 2022;14(18):4499.","journal-title":"Cancers (Basel)"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01418-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01418-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01418-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T10:04:31Z","timestamp":1705658671000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01418-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01418-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the guidelines established by the Declaration of Helsinki and was approved by the Institutional Review Board of Chungbuk National University Hospital (Cheongju, Korea, IRB No: 2023\u201301-018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}